Literature DB >> 23770020

Selective elimination/RNAi silencing of FMRF-related peptides and their receptors decreases the locomotor activity in Drosophila melanogaster.

Brigitta Kiss1, Tamás Szlanka, Ágnes Zvara, Michal Žurovec, Michal Sery, Štefan Kakaš, Beáta Ramasz, Zoltán Hegedűs, Tamás Lukacsovich, László Puskás, Adrien Fónagy, István Kiss.   

Abstract

Five neuropeptide genes are classified in the FMRF-related (FaRP) group: the Fmrf, dromyosuppressin (Dms), drosulfakinin (Dsk), neuropeptide F (npf) and short neuropeptide F (sNPF) genes coding for 8, 1, 2, 1 and 4 peptides, respectively. In order to compare their effects on the locomotor activity of Drosophila adults, we made RNAi knockdown of the peptides and their specific receptor genes. In addition, we constructed Gal4 drivers with three distinct parts of the Fmrf gene's 5' regulatory sequence (RS8-Gal4, RS11-Gal4, RS17-Gal4), and used them to ablate FMRF-positive neurons inducing apoptosis by expressing the reaper (rpr) gene. We examined the locomotor activity of flies by measuring the mean velocity of movement (MVM) following repeated air-puffs. Locomotor activity was decreased by RNAi knockdown induced in the CNS by the elav-Gal4 driver. According to the MVM curve profiles, RNAi knockdown most effectively decreased the velocity when the DmsR-1 and DmsR-2 genes were silenced together (DmsR-1-RNAi/elav-Gal4; DmsR-2-RNAi/+). Similar effect was observed in Dsk-RNAi/ elav-Gal4; DskR-2-RNAi/+, while moderate effects were found in three other combinations (Fmrf-RNAi/elav-Gal4; FR-RNAi/+, Dms-RNAi/ elav-Gal4;DmsR-2-RNAi/+, CCKLR-17D1-RNAi/elav-Gal4; CCKLR-17D3-RNAi/+), and weak effect in DmsR-2-RNAi/elav-Gal4; DmsR-1-RNAi/+. Male and female flies were not different in this respect. In the cell ablation experiment, the MVM profiles of the female flies were different from the controls when the UAS-rpr transgene was driven by RS8-Gal4 or RS17-Gal4. The RS11-Gal4 and Fmrf-Gal4 drivers were ineffective. In the males only the RS17-Gal4 showed a weak effect. RNAi silencing of the FaRP and FaRP-receptor genes effectively decreased the startle-induced locomotor activity of flies. Ablation of FMRF-positive neurons by the RS8-Gal4 and/or RS17-Gal4 drivers also decreased the flies' activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drosophila melanogaster; FMRF-related peptides; G protein-coupled receptors; Locomotor activity; RNAi-silencing; UAS-reaper ablation

Mesh:

Substances:

Year:  2013        PMID: 23770020     DOI: 10.1016/j.ygcen.2013.05.023

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  5 in total

1.  FMRFamide signaling promotes stress-induced sleep in Drosophila.

Authors:  Olivia Lenz; Jianmei Xiong; Matthew D Nelson; David M Raizen; Julie A Williams
Journal:  Brain Behav Immun       Date:  2015-02-07       Impact factor: 7.217

2.  Signaling properties and pharmacological analysis of two sulfakinin receptors from the red flour beetle, Tribolium castaneum.

Authors:  Sven Zels; Heleen Verlinden; Senne Dillen; Rut Vleugels; Ronald J Nachman; Jozef Vanden Broeck
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

3.  Neurogenomic Signatures of Successes and Failures in Life-History Transitions in a Key Insect Pollinator.

Authors:  Fabio Manfredini; Alfonso E Romero; Inti Pedroso; Alberto Paccanaro; Seirian Sumner; Mark J F Brown
Journal:  Genome Biol Evol       Date:  2017-11-01       Impact factor: 3.416

4.  Prepulse inhibition in Drosophila melanogaster larvae.

Authors:  Yutaro Matsumoto; Kazuya Shimizu; Kota Arahata; Miku Suzuki; Akira Shimizu; Koki Takei; Junji Yamauchi; Satoko Hakeda-Suzuki; Takashi Suzuki; Takako Morimoto
Journal:  Biol Open       Date:  2018-09-27       Impact factor: 2.422

5.  FMRFa receptor stimulated Ca2+ signals alter the activity of flight modulating central dopaminergic neurons in Drosophila melanogaster.

Authors:  Preethi Ravi; Deepti Trivedi; Gaiti Hasan
Journal:  PLoS Genet       Date:  2018-08-15       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.